BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38616346)

  • 1. Molecular insights into the potential effects of selective estrogen receptor β agonists in Alzheimer's and Parkinson's diseases.
    Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj D
    Cell Biochem Funct; 2024 Apr; 42(3):e4014. PubMed ID: 38616346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models.
    Rymbai E; Sugumar D; Chakkittukandiyil A; Kothandan R; Selvaraj J; Selvaraj D
    Life Sci; 2023 Nov; 333():122144. PubMed ID: 37797687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease.
    Lan YL; Zhao J; Li S
    J Alzheimers Dis; 2015; 43(4):1137-48. PubMed ID: 25159676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.
    Jonsson P; Katchy A; Williams C
    Endocr Relat Cancer; 2014 Apr; 21(2):143-60. PubMed ID: 24192230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin.
    Liang K; Yang L; Yin C; Xiao Z; Zhang J; Liu Y; Huang J
    J Biol Chem; 2010 Jan; 285(2):935-42. PubMed ID: 19897485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
    Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
    Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contribution of estrogen receptors to the intestinal therapeutic effects of 17β-estradiol in a murine model of Parkinson's disease.
    Poirier AA; Côté M; Bourque M; Jarras H; Lamontagne-Proulx J; Morissette M; Paolo TD; Soulet D
    Brain Res Bull; 2022 Sep; 187():85-97. PubMed ID: 35781029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.
    Evers NM; van den Berg JH; Wang S; Melchers D; Houtman R; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
    J Steroid Biochem Mol Biol; 2014 Sep; 143():376-85. PubMed ID: 24923734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of specific target genes and biological responses by estrogen receptor subtype agonists.
    Leitman DC; Paruthiyil S; Vivar OI; Saunier EF; Herber CB; Cohen I; Tagliaferri M; Speed TP
    Curr Opin Pharmacol; 2010 Dec; 10(6):629-36. PubMed ID: 20951642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of aromatase and estrogen receptor alpha in cultured human dermal papilla cells by dexamethasone: a novel mechanism for selective action of estrogen via estrogen receptor beta?
    Thornton MJ; Nelson LD; Taylor AH; Birch MP; Laing I; Messenger AG
    J Invest Dermatol; 2006 Sep; 126(9):2010-8. PubMed ID: 16691199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Puerarin suppression of Aβ
    Li L; Xue Z; Chen L; Chen X; Wang H; Wang X
    Brain Res; 2017 Feb; 1657():87-94. PubMed ID: 27923632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous estrogen receptor beta is transcriptionally active in primary ovarian cells from estrogen receptor knockout mice.
    Mueller SO; Katzenellenbogen JA; Korach KS
    Steroids; 2004 Sep; 69(10):681-6. PubMed ID: 15465114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice.
    Yan QY; Lv JL; Shen XY; Ou-Yang XN; Yang JZ; Nie RF; Lu J; Huang YJ; Wang JY; Shen X
    Acta Pharmacol Sin; 2022 Sep; 43(9):2226-2241. PubMed ID: 35091686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.